Finix 20 mg (Capsule (Enteric Coated))
Medicine Details
Category | Details |
---|---|
Generic | Rabeprazole sodium |
Company | Opsonin pharma ltd |
Also available as |
Indications
- Active duodenal ulcer
- Active benign gastric ulcer
- Symptomatic erosive or ulcerative gastro-esophageal reflux disease (GERD)
- Gastro-esophageal Reflux Disease Long-term Management (GERD Maintenance)
- Symptomatic treatment of moderate to very severe gastro-esophageal reflux disease (symptomatic GERD)
- Zollinger-Ellison Syndrome
- In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori in patients with peptic ulcer disease.
Pharmacology
Rabeprazole suppresses gastric acid secretion by inhibiting the gastric H+/K+-ATPase at the secretory surface of the gastric parietal cell.
Dosage
- 20 mg to be taken once daily in the morning for active duodenal ulcer and active benign gastric ulcer
- 20 mg to be taken once daily for four to eight weeks for erosive or ulcerative gastro-esophageal reflux disease (GERD)
- Maintenance dose of rabeprazole sodium 20 mg or 10 mg once daily for long-term management
- 10 mg once daily for symptomatic treatment of moderate to very severe gastro-esophageal reflux disease (symptomatic GERD)
- 5 mg once daily for pediatric patients 1 to 11 years of age (Less than 15 kg)
- 10 mg once daily for pediatric patients 1 to 11 years of age (15 kg or more)
- 60 mg once a day for Zollinger-Ellison Syndrome
- Eradication therapy: Rabeprazole sodium 20 mg twice daily, clarithromycin 500 mg twice daily, and amoxicillin 1g twice daily for 7 days.
Administration
Rabeprazole tablets should be taken in the morning, before eating, and swallowed whole.
Interaction
Co-administration with ketoconazole or itraconazole may result in a significant decrease in antifungal plasma levels; no interaction with liquid antacids observed; atazanavir absorption is pH-dependent.
Contraindications
Hypersensitivity to the active substance or to any of the excipients; contra-indicated in pregnancy and during breastfeeding.
Side Effects
- Headache
- Diarrhoea
- Abdominal pain
- Vomiting
- Constipation
- Dry mouth
- Increased or decreased appetite
- Muscle pain
- Drowsiness
- Dizziness
Pregnancy & Lactation
US FDA pregnancy category 'C'; likely excreted in human milk; a decision should be made whether to discontinue nursing or discontinue the drug.
Precautions & Warnings
- Symptomatic response to therapy does not preclude the presence of gastric or oesophageal malignancy
- Regular surveillance for patients on long-term treatment
- Modestly increased risk of hip, wrist, and spine fracture
- Risk of cross-hypersensitivity reactions with other proton pump inhibitors
- Potential of blood dyscrasias and hepatic enzyme abnormalities
- Severe hypomagnesaemia reported in patients treated with PPIs
- Reduction in absorption of vitamin B12
- Association with subacute cutaneous lupus erythematosus (SCLE)
- Interference with laboratory tests
Use in Special Populations
- No dosage adjustment necessary for patients with renal or hepatic impairment
- Not recommended for use in children
Overdose Effects
Maximum established exposure has not exceeded 60 mg twice daily or 160 mg once daily; effects are generally minimal, representative of the known adverse event profile and reversible without further medical intervention.
Therapeutic Class
Proton Pump Inhibitor
Storage Conditions
Keep below 30°C temperature, away from light & moisture; keep out of the reach of children.
Chemical Structure
- Molecular Formula: C18H21N3O3S
- Chemical Structure Image: https://medex.com.bd/storage/res/g-res-942-rabeprazole-sodium-chemical-structure-atwg0Q4PlndQZhOY9GHX.svg
Common Questions about Finix 20 mg Capsule
- Proton pump inhibitor (PPI) that suppresses gastric acid secretion
- Used to treat duodenal ulcer, gastric ulcer, GERD, Zollinger-Ellison Syndrome, Helicobacter pylori eradication
- Common side effects include diarrhea, constipation, nausea, vomiting, headache, dizziness, and dry mouth
- Should be taken with food; length of treatment depends on the condition being treated
Quick Tips
- Well-tolerated medicine providing long-term relief
- Avoid eating late at night or before bedtime
- Inform doctor about persistent symptoms
- Long-term use may cause weak bones and a deficiency of minerals such as magnesium
Related Brands
- Rabipep 20 mg (Tablet (Enteric Coated)) - novatek-pharmaceuticals-ltd
- Rabepra 20 mg (Capsule (Enteric Coated)) - euro-pharma-ltd
- Rabeprol 20 mg (Capsule (Enteric Coated)) - somatec-pharmaceuticals-ltd
- Rabenaaf 20 mg (Capsule (Enteric Coated)) - naafco-pharma-ltd
- Gastrazole 20 mg (Tablet (Enteric Coated)) - al-madina-pharmaceuticals-ltd